住院儿童和青少年中的百日咳博德特菌:疫苗接种延迟的影响,意大利托斯卡纳,2016至2024年
研究分析了2016至2024年意大利托斯卡纳一家三级医院收治的384例≤16岁实验室确诊百日咳住院病例,年病例数从2016-2019年平均28.2例增至2024年259例,其中青少年136例(52.5%)。12-16岁107例中93例(86.9%)未接种或未接种第二剂加强针,从最早可接种日至住院间隔中位数在婴儿第一剂为31天、12-16岁第二剂加强针为395天。结论认为提前接种青少年加强针、在最早可接种时间点接种及针对性沟通宣传可能减少百日咳相关住院。
要点
- 2016-2024年共384例≤16岁实验室确诊百日咳住院病例,年病例数从2016-2019年平均28.2例增至2024年259例。
- 12-16岁107例中93例(86.9%)未接种或未接种第二剂加强针。
- 婴儿从最早可接种日至住院间隔中位数第一剂31天、第二剂44天、第三剂53天;12-16岁第二剂加强针395天。
核心结论
- 提前接种青少年加强针、在最早可接种时间点接种及通过针对性沟通宣传促进及时接种,可能减少百日咳相关住院。
研究设计与样本
- 收集2016-2024年意大利托斯卡纳一家三级医院收治的≤16岁实验室确诊百日咳住院儿童和青少年数据,共384例。
主要发现
- 年病例数从2016-2019年平均28.2例增至2024年259例,其中青少年136例(52.5%)。
- 12-16岁107例中93例(86.9%)未接种或未接种第二剂加强针。
- 婴儿从最早可接种日至住院间隔中位数第一剂31天(IQR 10-131天)、第二剂44天(IQR 22-70天)、第三剂53天。
- 12-16岁第二剂加强针从最早可接种日至住院间隔中位数395天(IQR 236-717天)。
临床怎么用
- 作者认为提前接种青少年加强针、在最早可接种时间点接种及通过针对性沟通宣传促进及时接种,可能减少百日咳相关住院。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDPertussis is a highly contagious respiratory infection caused by Bordetella pertussis. Vaccination against pertussis is included in the Italian vaccination programme with three doses administered at 3, 5 and 11 months, booster doses at 6 and 12-18 years, and every 10 years. Vaccination coverage in Tuscany is high among infants (97.7% vs 94.7% national average at 24 months) and adolescents (75.8% vs 68.4% national average at 16 years).AIMWe aimed to investigate case numbers, vaccination status and time points for vaccination of children and adolescents hospitalised for pertussis.METHODSWe collected data on children and adolescents aged ≤ 16 years and hospitalised for laboratory-confirmed pertussis in 2016-2024 at a tertiary hospital in Tuscany.RESULTSA total of 384 children and adolescents were hospitalised in 2016-2024. Annual case numbers increased from an average of 28.2 cases in 2016-2019 to 259 cases in 2024, with 136 (52.5%) cases in adolescents. Of the 107 cases aged 12-16 years, 93 (86.9%) were unvaccinated or had not received the second booster. A considerable time gap between the earliest eligible day for vaccination and hospitalisation was observed. In infants, a median of 31 days (interquartile range (IQR): 10-131 days) was noticed for the first dose, 44 days (IQR: 22-70 days) for the second and 53 days for the third. In 12-16-year-olds, a median of 395 days (IQR: 236-717) was seen for the second booster.CONCLUSIONAdministering adolescent booster doses earlier, vaccinating at the earliest eligible time points, and promoting timely vaccination through targeted communication campaigns may reduce pertussis-related hospitalisations.
引用
- Nieddu F, Quaranta F, Vignoli M, et al. Bordetella pertussis in hospitalised children and adolescents: the impact of vaccination delay, Tuscany, Italy, 2016 to 2024. Euro Surveill. 2025. PMID: 40878704. doi:10.2807/1560-7917.ES.2025.30.34.2500062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。